{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:06:28Z","timestamp":1790233588697,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.mce.2013.01.005","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T17:29:30Z","timestamp":1359998970000},"page":"61-67","source":"Crossref","is-referenced-by-count":36,"title":["Polycystic ovarian syndrome during puberty and adolescence"],"prefix":"10.1016","volume":"373","author":[{"given":"Rachel M.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken K.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Dunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2013.01.005_b0155","unstructured":"Ahmed, M.L., 2008. Endocrine changes during puberty. PhD Thesis: Pubertal Growth in Diabetic Children."},{"key":"10.1016\/j.mce.2013.01.005_b0040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1210\/jc.84.3.899","article-title":"Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition","volume":"84","author":"Ahmed","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0230","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1515\/JPEM.2005.18.8.761","article-title":"Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome","volume":"18","author":"Allen","year":"2005","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jcem-72-2-277","article-title":"Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism","volume":"72","author":"Amiel","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0090","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2265.1985.tb00165.x","article-title":"Premenarcheal endocrine changes in relation to age at menarche","volume":"22","author":"Apter","year":"1985","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.mce.2013.01.005_b0015","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.82.10.3213","article-title":"Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism","volume":"82","author":"Arslanian","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0280","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.87.4.1555","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance. amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0300","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(02)04914-2","article-title":"Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome","volume":"79","author":"Azziz","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2013.01.005_b0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2013.01.005_b0135","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.mce.2013.01.005_b0290","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpedi.160.3.241","article-title":"Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome","volume":"160","author":"Bridger","year":"2006","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.mce.2013.01.005_b0115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0015-0282(16)56160-3","article-title":"Standards for ovarian volume in childhood and puberty","volume":"60","author":"Bridges","year":"1993","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2013.01.005_b0150","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-3476(89)80438-X","article-title":"Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity","volume":"114","author":"Caprio","year":"1989","journal-title":"J. Pediatr."},{"key":"10.1016\/j.mce.2013.01.005_b0180","doi-asserted-by":"crossref","unstructured":"Carmina, E., Oberfield, S.E., Lobo, R.A., 2010 The diagnosis of polycystic ovary syndrome in adolescents. Am. J. Obstet. Gynecol. 203, 201 e1\u20135.","DOI":"10.1016\/j.ajog.2010.03.008"},{"key":"10.1016\/j.mce.2013.01.005_b0235","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1749-6632.2000.tb06236.x","article-title":"Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile","volume":"900","author":"Creatsas","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.mce.2013.01.005_b0080","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1542\/peds.2006-2481","article-title":"Menstruation in girls and adolescents: using the menstrual cycle as a vital sign","volume":"118","author":"Diaz","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.mce.2013.01.005_b0315","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1210\/jc.81.9.3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-2002-32505","article-title":"Leptin and the onset of puberty: insights from rodent and human genetics","volume":"20","author":"Farooqi","year":"2002","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.mce.2013.01.005_b0175","doi-asserted-by":"crossref","unstructured":"Fauser, B.C., Tarlatzis, B.C., Rebar, R.W., Legro, R.S., Balen, A.H., Lobo, R., Carmina, E., Chang, J., Yildiz, B.O., Laven, J.S., Boivin, J., Petraglia, F., Wijeyeratne, C.N., Norman, R.J., Dunaif, A., Franks, S., Wild, R.A., Dumesic, D. and Barnhart, K., 2012. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 97, 28\u201338 e25.","DOI":"10.1016\/j.fertnstert.2011.09.024"},{"key":"10.1016\/j.mce.2013.01.005_b0265","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humrep\/dem379","article-title":"Cyproterone acetate\/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy","volume":"23","author":"Franks","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2013.01.005_b0335","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study","volume":"89","author":"Ganie","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0310","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/09513590500430575","article-title":"Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome","volume":"21","author":"Garmes","year":"2005","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.mce.2013.01.005_b0285","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.metabol.2005.11.003","article-title":"Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents","volume":"55","author":"Glueck","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2013.01.005_b0365","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.mce.2013.01.005_b0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/humupd\/dmg038","article-title":"Menstrual disorders in adolescence. investigation and management","volume":"9","author":"Hickey","year":"2003","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.mce.2013.01.005_b0370","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/humrep\/der102","article-title":"Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis","volume":"26","author":"Hickey","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.mce.2013.01.005_b0200","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"Hoeger","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0220","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ibanez","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0050","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1210\/jc.76.6.1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism","volume":"76","author":"Ibanez","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0025","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1210\/er.21.6.671","article-title":"Premature adrenarche \u2013 normal variant or forerunner of adult disease?","volume":"21","author":"Ibanez","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2013.01.005_b0295","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1210\/jc.85.10.3526","article-title":"Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche","volume":"85","author":"Ibanez","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0345","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.85.9.3251","article-title":"Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide","volume":"85","author":"Ibanez","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0030","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2004-0463","article-title":"Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment","volume":"89","author":"Ibanez","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2003.08.015","article-title":"Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome","volume":"144","author":"Ibanez","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.mce.2013.01.005_b0350","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/humrep\/dei004","article-title":"Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women","volume":"20","author":"Ibanez","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2013.01.005_b0320","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/jc.2006-2684","article-title":"Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess","volume":"92","author":"Ibanez","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0330","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2265.2007.03137.x","article-title":"Pioglitazone (7.5mg\/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin","volume":"68","author":"Ibanez","year":"2008","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.mce.2013.01.005_b0325","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.2008.03472.x","article-title":"Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months","volume":"71","author":"Ibanez","year":"2009","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.mce.2013.01.005_b0125","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/humrep\/dei159","article-title":"Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries","volume":"20","author":"Jonard","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2013.01.005_b0160","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.fertnstert.2005.10.057","article-title":"Serum anti-mullerian hormone levels in women with secondary amenorrhea","volume":"85","author":"La Marca","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2013.01.005_b0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/01674820802546204","article-title":"Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Kuster-Hauser syndrome","volume":"30","author":"Laggari","year":"2009","journal-title":"J. Psychosom. Obstet. Gyn."},{"key":"10.1016\/j.mce.2013.01.005_b0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1067\/mpd.2001.109603","article-title":"Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome","volume":"138","author":"Lewy","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.mce.2013.01.005_b0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.mce.2013.01.005_b0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13625180701300194","article-title":"Combined hormonal contraception and venous thromboembolism","volume":"12","author":"Martinez","year":"2007","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.mce.2013.01.005_b0240","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2013.01.005_b0245","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.mce.2013.01.005_b0195","doi-asserted-by":"crossref","unstructured":"Ornstein, R.M., Copperman, N.M., Jacobson, M.S., 2011. Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome. J. Pediatr. Adolesc. Gynecol.","DOI":"10.1016\/j.jpag.2011.01.002"},{"key":"10.1016\/j.mce.2013.01.005_b0075","doi-asserted-by":"crossref","unstructured":"PCOS, 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19, 41-7.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.mce.2013.01.005_b0170","doi-asserted-by":"crossref","unstructured":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS). Hum Reprod 27, 14\u201324.","DOI":"10.1093\/humrep\/der396"},{"key":"10.1016\/j.mce.2013.01.005_b0305","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/humrep\/dei505","article-title":"Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study","volume":"21","author":"Rautio","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2013.01.005_b0210","doi-asserted-by":"crossref","unstructured":"Reinehr, T., Widhalm, K., l\u2019Allemand, D., Wiegand, S., Wabitsch, M. and Holl, R.W., 2009. Two-year follow-up in 21,784 overweight children and adolescents with lifestyle intervention. Obesity (Silver Spring) 17, 1196\u20139.","DOI":"10.1038\/oby.2009.17"},{"key":"10.1016\/j.mce.2013.01.005_b0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jpepsy\/jsn057","article-title":"Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study","volume":"34","author":"Rofey","year":"2009","journal-title":"J. Pediatr. Psychol."},{"issue":"Suppl 5","key":"10.1016\/j.mce.2013.01.005_b0035","first-page":"1285","article-title":"Diagnosis of the polycystic ovary syndrome in adolescence. comparison of adolescent and adult hyperandrogenism","volume":"13","author":"Rosenfield","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000075960","article-title":"Antiandrogen monotherapy: recommendations for the treatment of prostate cancer","volume":"72","author":"Sciarra","year":"2004","journal-title":"Urol. Int."},{"key":"10.1016\/j.mce.2013.01.005_b0260","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humrep\/deg120","article-title":"The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study","volume":"18","author":"Seaman","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2013.01.005_b0270","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.896","article-title":"Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK general practice research database","volume":"13","author":"Seaman","year":"2004","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.mce.2013.01.005_b0140","series-title":"Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome","author":"Shah","year":"2009"},{"key":"10.1016\/j.mce.2013.01.005_b0375","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1471-0528.2009.02421.x","article-title":"Reproductive endocrinology of adolescent polycystic ovary syndrome","volume":"117","author":"Shayya","year":"2010","journal-title":"Bjog"},{"key":"10.1016\/j.mce.2013.01.005_b0165","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1210\/jc.2005-2693","article-title":"Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome","volume":"91","author":"Sir-Petermann","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0145","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2008-2836","article-title":"Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Sir-Petermann","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/adc.60.2.116","article-title":"Ovarian ultrasound assessment in normal children, idiopathic precocious puberty, and during low dose pulsatile gonadotrophin releasing hormone treatment of hypogonadotrophic hypogonadism","volume":"60","author":"Stanhope","year":"1985","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.mce.2013.01.005_b0205","doi-asserted-by":"crossref","unstructured":"Tang, T., Lord, J.M., Norman, R.J., Yasmin, E., Balen, A.H., 2009. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev, CD003053.","DOI":"10.1002\/14651858.CD003053.pub3"},{"key":"10.1016\/j.mce.2013.01.005_b0215","series-title":"Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy","author":"Teede","year":"2008"},{"key":"10.1016\/j.mce.2013.01.005_b0380","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2010-2547","article-title":"Drospirenone\/Ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors","volume":"96","author":"Tfayli","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2013.01.005_b0250","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000081585","article-title":"Hepatotoxicity induced by antiandrogens: a review of the literature","volume":"73","author":"Thole","year":"2004","journal-title":"Urol. Int."},{"key":"10.1016\/j.mce.2013.01.005_b0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0378-5122(81)90032-3","article-title":"Menstrual cyclicity and the pre-menopause","volume":"3","author":"Treloar","year":"1981","journal-title":"Maturitas"},{"key":"10.1016\/j.mce.2013.01.005_b0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2013.01.005_b0120","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1203\/00006450-199512000-00024","article-title":"Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence","volume":"38","author":"Venturoli","year":"1995","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.mce.2013.01.005_b0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0022-4731(84)90209-7","article-title":"Endocrine characteristics of adolescent menstrual cycles: impact of early menarche","volume":"20","author":"Vihko","year":"1984","journal-title":"J. Steroid. Biochem."},{"key":"10.1016\/j.mce.2013.01.005_b0065","series-title":"Polycystic Ovary Syndrom","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1995"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720713000282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720713000282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T06:41:14Z","timestamp":1562654474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720713000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":70,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0303720713000282"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2013.01.005","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}